Advertisement
JOGC

Epidemiology and Effects of Substance Use in Pregnancy

      Abstract

      Substance use during pregnancy has important implications for health care providers and policymakers and can negatively affect a woman's health and the health of her children. Understanding trends, patterns of use, and outcomes are critical to developing prevention campaigns, building awareness, and providing effective care. This review critically examines the current literature on substance use in pregnancy and during the postpartum period in terms of epidemiology, risk factors, and implications. The risk factors for substance use in pregnancy, the challenges associated with reporting these cases, and the adverse effects of common substances on maternal and fetal health are discussed.

      Résumé

      La consommation durant la grossesse, qui peut nuire à la santé de la mère et de l'enfant, a une forte incidence sur les décisions des fournisseurs de soins de santé et des responsables de politiques. Il est essentiel de comprendre les tendances, les habitudes de consommation et les résultats connexes pour élaborer des campagnes de prévention, sensibiliser les femmes et offrir des soins efficaces. Cette étude analyse de façon critique la littérature sur la consommation durant la grossesse et le postpartum et s'intéresse à l'épidémiologie, aux facteurs de risque et aux conséquences. Y sont abordés les facteurs de risque de la consommation durant la grossesse, les obstacles rencontrés lors de la déclaration des cas et les effets nocifs des substances courantes sur la santé de la mère et de l'enfant.

      Key Words

      Abbreviations:

      ACE (adverse childhood experience), DSM-5 (Diagnostic and Statistical Manual of Mental Disorders-5), FASD (fetal alcohol spectrum disorder)
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Journal of Obstetrics and Gynaecology Canada
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • World Health Organization
        Substance use.
        WHO., Geneva, Switzerland2017 (Available at:)
        • American Psychiatric Association
        Diagnostic and statistical manual of mental disorders.
        5th ed. American Psychiatric Association Publishing, Arlington, VA2013
        • Managing obstetrical risk efficiently (MOREOB)
        (Salus Global; Available at:)
        http://moreob.com/
        Date accessed: September 1, 2017
        • Kaplan G.B.
        • Hammer R.P.
        Brain circuitry and signaling in psychiatry: basic science and clinical implications.
        American Psychiatric Association Publishing, Arlington, VA2002
        • Centers for Disease Control and Prevention
        Adverse childhood experiences (ACEs).
        Centers for Disease Control and Prevention, Atlanta, GA2016 (Available at:)
        • Sternberg E.M.
        • Chrousos G.P.
        • Wilder R.L.
        • et al.
        The stress response and the regulation of inflammatory disease.
        Ann Intern Med. 1992; 117: 854-866
        • Waffarn F.
        • Davis E.P.
        Effects of antenatal corticosteroids on the hypothalamic-pituitary-adrenocortical axis of the fetus and newborn: experimental findings and clinical considerations.
        Am J Obstet Gynecol. 2012; 207: 446-454
        • United States Department of Health
        • Human Services
        Substance Abuse, Mental Health Services Administration. Center for Behavioral Health Statistics and Quality: National Survey on Drug Use and Health, 2012. Inter-university Consortium for Political and Social Research (ICPSR) [distributor].
        2013
        • Health Canada
        Canadian alcohol and drug use monitoring survey.
        Health Canada, Ottawa2014 (Available at:)
        • Stinson F.S.
        • Grant B.F.
        • Dawson D.A.
        • et al.
        Comorbidity between DSM-IV alcohol and specific drug use disorders in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions.
        Drug Alcohol Depend. 2005; 80: 105-116
        • Steingrimsson S.
        • Carlsen H.K.
        • Sigfusson S.
        • et al.
        The changing gender gap in substance use disorder: a total population-based study of psychiatric in-patients.
        Addiction. 2012; 107: 1957-1962
        • Keyes K.M.
        • Grant B.F.
        • Hasin D.S.
        Evidence for a closing gender gap in alcohol use, abuse, and dependence in the United States population.
        Drug Alcohol Depend. 2008; 93: 21-29
        • Compton W.M.
        • Thomas Y.F.
        • Stinson F.S.
        • et al.
        Prevalence, correlates, disability, and comorbidity of DSM-IV drug abuse and dependence in the United States: results from the national epidemiologic survey on alcohol and related conditions.
        Arch Gen Psychiatry. 2007; 64: 566-576
        • Ebrahim S.H.
        • Gfroerer J.
        Pregnancy-related substance use in the United States during 1996–1998.
        Obstet Gynecol. 2003; 101: 374-379
        • Finnegan L.
        Substance abuse in Canada. Licit and illicit drug use during pregnancy: maternal, neonatal and ealry childhood consequences.
        Canadian Centre on Substance Abuse, Ottawa2013 (Available at:)
        • Howell E.M.
        • Heiser N.
        • Harrington M.
        A review of recent findings on substance abuse treatment for pregnant women.
        J Subst Abuse Treat. 1999; 16: 195-219
        • Crome I.B.
        • Ismail K.M.K.
        • Birnbach D.
        Substance misuse in pregnancy.
        in: Powrie M.F. Greene M.F. Camann W. de Swiet's medical disorders in obstetric practice. Wiley-Blackwell, West Sussex, UK2010: 477-504
        • Crome I.B.
        • Kumar M.T.
        Epidemiology of drug and alcohol use in young women.
        Semin Fetal Neonatal Med. 2007; 12: 98-105
        • National Treatment Agency for Substance Misuse
        • Department of Health [DoH]
        Models of care for substance misuse treatment.
        (London, UK)0-9544534-0-92002
        • Center for Behavioral Health Statistics and Quality
        Substance use during pregnancy varies by race and ethnicity.
        Substance Abuse and Mental Health Services Administration, Rockville, MD2012 (Available at:)
        • Forray A.
        • Foster D.
        Substance use in the perinatal period.
        Curr Psychiatry Rep. 2015; 17: 91
        • Public Health Agency of Canada
        What mothers say: the Canadian maternity experiences survey.
        Public Health Agency of Canada, Ottawa2009 (Available at:)
        • Public Health Agency of Canada
        Perinatal health indicators for Canada 2013: a report of the Canadian perinatal surveillance system.
        Public Health Agency of Canada, Ottawa2013 (Available at:)
        • Substance Abuse and Mental Health Services Administration
        Results from the 2010 national survey on drug use and health: summary of national findings.
        Substance Abuse and Mental Health Services Administration, Rockville, MD2011 (Available at:)
        • Substance Abuse and Mental Health Services Administration
        The NSDUH report: substance use among women during pregnancy and following childbirth.
        Substance Abuse and Mental Health Services Administration, Rockville, MD2009 (Available at:)
        • Hayes M.J.
        • Brown M.S.
        Epidemic of prescription opiate abuse and neonatal abstinence.
        JAMA. 2012; 307: 1974-1975
        • Desai R.J.
        • Hernandez-Diaz S.
        • Bateman B.T.
        • et al.
        Increase in prescription opioid use during pregnancy among Medicaid-enrolled women.
        Obstet Gynecol. 2014; 123: 997-1002
        • Ailes E.C.
        • Dawson A.L.
        • Lind J.N.
        • et al.
        Opioid prescription claims among women of reproductive age—United States, 2008–2012.
        MMWR Morb Mortal Wkly Rep. 2015; 64: 37-41
        • Yazdy M.M.
        • Desai R.J.
        • Brogly S.B.
        Prescription opioids in pregnancy and birth outcomes: a review of the literature.
        J Pediatr Genet. 2015; 4: 56-70
        • Warren M.D.
        • Miller A.M.
        • Traylor J.
        • et al.
        Centers for Disease Control and Prevention. Implementation of a statewide surveillance system for neonatal abstinence syndrome - Tennessee, 2013.
        MMWR Morb Mortal Wkly Rep. 2015; 64: 125-128
        • Cicero T.J.
        • Ellis M.S.
        • Harney J.
        Shifting patterns of prescription opioid and heroin abuse in the United States.
        N Engl J Med. 2015; 373: 1789-1790
        • Gomes T.
        • Juurlink D.N.
        Opioid use and overdose: what we've learned in Ontario.
        Healthc Q. 2016; 18: 8-11
        • Jansson L.M.
        • Velez M.
        Neonatal abstinence syndrome.
        Curr Opin Pediatr. 2012; 24: 252-258
        • Krans E.E.
        • Cochran G.
        • Bogen D.L.
        Caring for opioid-dependent pregnant women: prenatal and postpartum care considerations.
        Clin Obstet Gynecol. 2015; 58: 370-379
        • Jumah N.A.
        Rural, pregnant, and opioid dependent: a systematic review.
        Subst Abuse. 2016; 10: 35-41
        • El Marroun H.
        • Tiemeier H.
        • Jaddoe V.W.
        • et al.
        Demographic, emotional and social determinants of cannabis use in early pregnancy: the Generation R study.
        Drug Alcohol Depend. 2008; 98: 218-226
        • Passey M.E.
        • Sanson-Fisher R.W.
        • D'Este C.A.
        • et al.
        Tobacco, alcohol and cannabis use during pregnancy: clustering of risks.
        Drug Alcohol Depend. 2014; 134: 44-50
        • Bell R.
        • Rankin J.
        • Glinianaia S.
        • Pless-Mulloli T.
        Perinatal and Infant Health Information: A scoping study.
        (Northern & Yorkshire Public Health Observatory, Wolfson Research Institute, University of DurhamQueen's Campus, University of Boulevard, Stockton on Tees, UK)2001
        • Petersen Williams P.
        • Jordaan E.
        • Mathews C.
        • et al.
        Alcohol and other drug use during pregnancy among women attending midwife obstetric units in the Cape Metropole, South Africa.
        Adv Prev Med. 2014; 2014: 871427
        • Abbott P.
        • Chase D.
        Culture and substance abuse: impact of culture affects approach to treatment.
        Psychiatric Times. 2008; 25: 43-46
        • Lester B.M.
        • Andreozzi L.
        • Appiah L.
        Substance use during pregnancy: time for policy to catch up with research.
        Harm Reduct J. 2004; 1: 5
        • Matthews A.
        • Li C.C.
        • Aranda F.
        • et al.
        The influence of acculturation on substance use behaviors among Latina sexual minority women: the mediating role of discrimination.
        Subst Use Misuse. 2014; 49: 1888-1898
        • Wickstrom R.
        Effects of nicotine during pregnancy: human and experimental evidence.
        Curr Neuropharmacol. 2007; 5: 213-222
        • Cnattingius S.
        The epidemiology of smoking during pregnancy: smoking prevalence, maternal characteristics, and pregnancy outcomes.
        Nicotine Tob Res. 2004; 6: S125-S140
        • Chalmers B.
        • Dzakpasu S.
        • Heaman M.
        • et al.
        The Canadian maternity experiences survey: an overview of findings.
        J Obstet Gynaecol Can. 2008; 30: 217-228
        • Centers for Disease Control and Prevention
        PRAMS and smoking data tables.
        Centers for Disease Control and Prevention, Atlanta, GA2011 (Available at:)
        • Forray A.
        • Merry B.
        • Lin H.
        • et al.
        Perinatal substance use: a prospective evaluation of abstinence and relapse.
        Drug Alcohol Depend. 2015; 150: 147-155
        • Bobo J.K.
        • Klepinger D.H.
        • Dong F.B.
        Changes in the prevalence of alcohol use during pregnancy among recent and at-risk drinkers in the NLSY cohort.
        J Womens Health (Larchmt). 2006; 15: 1061-1070
        • Anderson A.E.
        • Hure A.J.
        • Forder P.M.
        • et al.
        Risky drinking patterns are being continued into pregnancy: a prospective cohort study.
        PLoS ONE. 2014; 9: e86171
        • Substance Abuse and Mental Health Services Administration
        Results from the 2012 national survey on drug use and health: summary of national findings.
        Substance Abuse and Mental Health Services Administration, Rockville, MD2013 (Available at:)
        • Vesga-Lopez O.
        • Blanco C.
        • Keyes K.
        • et al.
        Psychiatric disorders in pregnant and postpartum women in the United States.
        Arch Gen Psychiatry. 2008; 65: 805-815
        • Liyanage V.R.
        • Curtis K.
        • Zachariah R.M.
        • et al.
        Overview of the genetic basis and epigenetic mechanisms that contribute to FASD pathobiology.
        Curr Top Med Chem. 2017; 17: 808-828
        • Cook J.L.
        • Green C.R.
        • Lilley C.M.
        • et al.
        Fetal alcohol spectrum disorder: a guideline for diagnosis across the lifespan.
        CMAJ. 2016; 188: 191-197
        • Carson G.
        • Cox L.V.
        • Crane J.
        • et al.
        Alcohol use and pregnancy consensus clinical guidelines.
        J Obstet Gynaecol Can. 2010; 32: S1-31
        • Public Health Agency of Canada
        Fetal alcohol spectrum disorder (FASD).
        Public Health Agency of Canada;, Ottawa2017 (Available at:)
        • Flak A.L.
        • Su S.
        • Bertrand J.
        • et al.
        The association of mild, moderate, and binge prenatal alcohol exposure and child neuropsychological outcomes: a meta-analysis.
        Alcohol Clin Exp Res. 2014; 38: 214-226
        • Patrick S.W.
        • Schumacher R.E.
        • Benneyworth B.D.
        • et al.
        Neonatal abstinence syndrome and associated health care expenditures: United States, 2000–2009.
        JAMA. 2012; 307: 1934-1940
        • Substance Abuse and Mental Health Services Administration
        Results from the 2005 national survey on drug use and health: national findings.
        Substance Abuse and Mental Health Services Administration, Rockville, MD2006 (Available at:)
        • Substance Abuse and Mental Health Services Administration
        Results from the 2013 national survey on drug use and health: summary of national findings.
        Substance Abuse and Mental Health Services Administration, Rockville, MD2014 (Available at:)
        • Terplan M.
        • Smith E.J.
        • Kozloski M.J.
        • et al.
        Methamphetamine use among pregnant women.
        Obstet Gynecol. 2009; 113: 1285-1291
        • Hill M.
        • Reed K.
        Pregnancy, breast-feeding, and marijuana: a review article.
        Obstet Gynecol Surv. 2013; 68: 710-718
        • Moore D.G.
        • Turner J.D.
        • Parrott A.C.
        • et al.
        During pregnancy, recreational drug-using women stop taking ecstasy (3,4-methylenedioxy-N-methylamphetamine) and reduce alcohol consumption, but continue to smoke tobacco and cannabis: initial findings from the Development and Infancy Study.
        J Psychopharmacol. 2010; 24: 1403-1410
        • Volkow N.D.
        • Compton W.M.
        • Wargo E.M.
        The risks of marijuana use during pregnancy.
        JAMA. 2017; 317: 129-130
        • Buchi K.F.
        • Zone S.
        • Langheinrich K.
        • et al.
        Changing prevalence of prenatal substance abuse in Utah.
        Obstet Gynecol. 2003; 102: 27-30
        • Porath-Waller A.J.
        Clearing the Smoke on Cannabis: Maternal Cannabis Use during Pregnancy – An Update.
        (Canadian Centre on Substance Abuse; Available at:)
        • Jaques S.C.
        • Kingsbury A.
        • Henshcke P.
        • et al.
        Cannabis, the pregnant woman and her child: weeding out the myths.
        J Perinatol. 2014; 34: 417-424
        • Williamson S.
        • Jacobson L.
        • Skeoch C.
        • et al.
        Prevalence of maternal drug misuse by meconium analysis.
        Arch Dis Child. 2003; 88: 17-21
        • Lester B.M.
        • ElSohly M.
        • Wright L.L.
        • et al.
        The Maternal Lifestyle Study: drug use by meconium toxicology and maternal self-report.
        Pediatrics. 2001; 107: 309-317
        • American College of Obstetricians, Gynecologists Committee on Obstetric Practice
        Committee opinion No. 637: marijuana use during pregnancy and lactation.
        Obstet Gynecol. 2015; 126: 234-238
        • Stone R.
        Pregnant women and substance use: fear, stigma, and barriers to care.
        Health Justice. 2015; 3: 2
        • Bhuvaneswar C.G.
        • Chang G.
        • Epstein L.A.
        • et al.
        Cocaine and opioid use during pregnancy: prevalence and management.
        Prim Care Companion J Clin Psychiatry. 2008; 10: 59-65
        • National Institute on Drug Abuse
        National pregnancy.
        (NIDA Notes National Institute on Drug Abuse (NIDA) Notes; 12 (1); Available at:)
        • Wouldes T.A.
        • LaGasse L.L.
        • Derauf C.
        • et al.
        Co-morbidity of substance use disorder and psychopathology in women who use methamphetamine during pregnancy in the US and New Zealand.
        Drug Alcohol Depend. 2013; 127: 101-107
        • Bateman B.T.
        • Hernandez-Diaz S.
        • Rathmell J.P.
        • et al.
        Patterns of opioid utilization in pregnancy in a large cohort of commercial insurance beneficiaries in the United States.
        Anesthesiology. 2014; 120: 1216-1224
        • Bauer C.R.
        • Shankaran S.
        • Bada H.S.
        • et al.
        The Maternal Lifestyle Study: drug exposure during pregnancy and short-term maternal outcomes.
        Am J Obstet Gynecol. 2002; 186: 487-495
        • Pichini S.
        • Puig C.
        • Zuccaro P.
        • et al.
        Assessment of exposure to opiates and cocaine during pregnancy in a Mediterranean city: preliminary results of the “Meconium Project.
        Forensic Sci Int. 2005; 153: 59-65
        • Dyk J.
        • Ramanjam V.
        • Church P.
        • et al.
        Maternal methamphetamine use in pregnancy and long-term neurodevelopmental and behavioral deficits in children.
        J Popul Ther Clin Pharmacol. 2014; 21: e185-e196
        • Wong S.
        • Ordean A.
        • Kahan M.
        (Society of Ostetricians and Gynaecologists of Canada). SOGC clinical practice guidelines: substance use in pregnancy: No. 256, April 2011.
        Int J Gynaecol Obstet. 2011; 114: 190-202
        • Connor J.P.
        • Gullo M.J.
        • White A.
        • et al.
        Polysubstance use: diagnostic challenges, patterns of use and health.
        Curr Opin Psychiatry. 2014; 27: 269-275
        • Conway K.P.
        • Vullo G.C.
        • Nichter B.
        • et al.
        Prevalence and patterns of polysubstance use in a nationally representative sample of 10th graders in the United States.
        J Adolesc Health. 2013; 52: 716-723
        • Wong C.F.
        • Silva K.
        • Kecojevic A.
        • et al.
        Coping and emotion regulation profiles as predictors of nonmedical prescription drug and illicit drug use among high-risk young adults.
        Drug Alcohol Depend. 2013; 132: 165-171
        • Morley K.I.
        • Lynskey M.T.
        • Moran P.
        • et al.
        Polysubstance use, mental health and high-risk behaviours: results from the 2012 Global Drug Survey.
        Drug Alcohol Rev. 2015; 34: 427-437
        • Knight M.
        • Kenyon S.
        • Brocklehurst P.
        (Maternal, Newborn, and Infant Clinical Outcome Review Programme). Saving lives, improving mothers' care - lessons learned to inform future maternity care from the UK and Ireland confidential enquiries into maternal deaths and morbidity 2009-12.
        National Perinatal Epidemiology Unit, University of Oxford, Oxford, United Kingdom2014 (Available at:)
        • Knight M.
        • Tuffnell D.
        • Kenyon S.
        • et al.
        (Maternal, Newborn, and Infant Clinical Outcome Review Programme). Saving lives, improving mothers' care - surveillance of maternal deaths in the UK 2011-13 and lessons learned to inform maternity care from the UK and Ireland confidential enquiries into maternal deaths and Morbidity 2009-13.
        National Perinatal Epidemiology Unit, University of Oxford, Oxford, United Kingdom2015 (Available at:)
        • Centers for Disease Control and Prevention
        Persons who use drugs (PWUD).
        Centers for Disease Control and Prevention, Atlanta, GA2016 (Available at:)
        https://www.cdc.gov/pwud/
        Date accessed: July 31, 2017
        • McDonald S.W.
        • Hicks M.
        • Rasmussen C.
        • et al.
        Characteristics of women who consume alcohol before and after pregnancy recognition in a Canadian sample: a prospective cohort study.
        Alcohol Clin Exp Res. 2014; 38: 3008-3016
        • Powers J.R.
        • McDermott L.J.
        • Loxton D.J.
        • et al.
        A prospective study of prevalence and predictors of concurrent alcohol and tobacco use during pregnancy.
        Matern Child Health J. 2013; 17: 76-84
        • Substance Abuse and Mental Health Services
        Substance abuse treament: addressing the specific needs of women. A treatment improvement protocol (TIP) 51.
        Substance Abuse and Mental Health Services Administration, Rockville, MD2015 (Available at:)